Wolverine Trading, LLC Ocugen, Inc. Put Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $21,560 - $42,900	22,000 New	22,000 $21,000
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $21,250 - $77,775	42,500 New	42,500 $69,000
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.87 $47,175 - $79,475	42,500 New	42,500 $55,000
Q2 2022 Aug 15, 2022	SELL	$1.83 - $3.45 $200,202 - $377,430	-109,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.34 - $4.72 $255,995 - $516,368	109,400 New	109,400 $369,000
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $1 Million - $3.59 Million	-229,200 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.36 - $8.51 $568,584 - $760,794	-89,400 Reduced 28.06%	229,200 $1.56 Million
Q2 2021 Aug 06, 2021	BUY	$5.52 - $15.68 $1.76 Million - $5 Million	318,600 New	318,600 $2.7 Million

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.